It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The prevalence of mitral valve prolapse (MVP) among middle- and older-aged individuals is estimated to be 2–4% in Western countries. However, few studies have been conducted among Asian individuals and young adults. This study included a sample of 2442 consecutive military adults aged 18–39 years in Hualien, Taiwan. MVP was defined as displacement of the anterior or posterior leaflet of the mitral valve to the mid portion of the annular hinge point > 2 mm in the parasternal long-axis view of echocardiography. Cardiac chamber size and wall thickness were measured based on the latest criteria of the American Society of Echocardiography. The clinical features of participants with MVP and those without MVP were compared using a two-sample t test, and the cardiac structures were compared using analysis of covariance with adjustment for body surface area (BSA). Eighty-two participants were diagnosed with MVP, and the prevalence was 3.36% in the overall population. Compared with those without MVP, participants with MVP had a lower body mass index (kg/m2) (24.89 ± 3.70 vs. 23.91 ± 3.45, p = 0.02) and higher prevalence of somatic symptoms related to exercise (11.0% vs. 4.9%, p = 0.02) and systolic click in auscultation (18.3% vs. 0.6%, p < 0.01). In addition, participants with MVP had greater left ventricular mass (gm) and smaller right ventricular wall thickness (mm) and dimensions (mm) indexed by BSA than those without MVP (149.12 ± 35.76 vs. 155.38 ± 36.26; 4.66 ± 0.63 vs. 4.40 ± 0.68; 26.57 ± 3.99 vs. 25.41 ± 4.35, respectively, all p-values < 0.01). In conclusion, the prevalence and clinical features of MVP in military young adults in Taiwan were in line with those in Western countries. Whether the novel MVP phenotype found in this study has any pathological meaning needs further investigation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Tri-Service General Hospital and National Defense Medical Center, Division of Cardiology, Department of Internal Medicine, Taipei, Taiwan (GRID:grid.260565.2) (ISNI:0000 0004 0634 0356)
2 Hualien Armed Forces General Hospital, Department of Internal Medicine, Hualien City, Taiwan (GRID:grid.413601.1) (ISNI:0000 0004 1797 2578)
3 Taipei Tzu Chi General Hospital, Department of Critical Care Medicine, New Taipei City, Taiwan (GRID:grid.414692.c) (ISNI:0000 0004 0572 899X)
4 Hualien Armed Forces General Hospital, Department of Internal Medicine, Hualien City, Taiwan (GRID:grid.413601.1) (ISNI:0000 0004 1797 2578); GENEUS Medical Technology Co., New Taipei City, Taiwan (GRID:grid.413601.1)
5 University of Tokyo, Department of Cardiovascular Medicine, School of Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
6 Tri-Service General Hospital and National Defense Medical Center, Division of Cardiology, Department of Internal Medicine, Taipei, Taiwan (GRID:grid.260565.2) (ISNI:0000 0004 0634 0356); Hualien Armed Forces General Hospital, Department of Internal Medicine, Hualien City, Taiwan (GRID:grid.413601.1) (ISNI:0000 0004 1797 2578); Northwestern University Feinberg School of Medicine, Department of Preventive Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)




